Cục Thông tin KH&CN Quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu mới nhất về COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống từ ngày 07/05 đến ngày 14/05/2021. 


1. Expression of SARS coronavirus 1 spike protein from a herpesviral vector induces innate immune signaling and neutralizing antibody responses                           

Virology, 21 April 2021, Volume 559 (Cover date: July 2021), Pages 165-172

Evelyn A. Kurt-Jones, Timothy E. Dudek, David M. Knipe


2. Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers

International Journal of Infectious Diseases, 15 April 2021, Volume 106 (Cover date: May 2021), Pages 376-381

Renuka A. K. Kadali, Ravali Janagama, Srikrishna V. Malayala


3. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

The Lancet Public Health, 12 April 2021, Volume 6, Issue 5 (Cover date: May 2021), Pages e335-e345

Mark S Graham, Carole H Sudre, Sebastien Ourselin


4. The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18–59 years: A phase I randomized, double-blinded, controlled trial

Vaccine, 9 April 2021, Volume 39, Issue 20 (Cover date: 12 May 2021), Pages 2746-2754

Jing Pu, Qin Yu, Qihan Li


5. Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals

Bioorganic Chemistry, 8 April 2021, Volume 112 (Cover date: July 2021), Article 104889

Le-Yun Sun, Cheng Chen, Ke-Wu Yang


6. Immunogenicity and antigenicity based T-cell and B-cell epitopes identification from conserved regions of 10664 SARS-CoV-2 genomes

Infection, Genetics and Evolution, 2 April 2021, Volume 92 (Cover date: August 2021), Article 104823

Nimisha Ghosh, Nikhil Sharma, Indrajit Saha


7. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

The Lancet, 30 March 2021, Volume 397, Issue 10282 (Cover date: 10–16 April 2021), Pages 1351-1362

Katherine R W Emary, Tanya Golubchik, Andrew J Pollard


8. Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay

Bioorganic Chemistry, 29 March 2021, Volume 111 (Cover date: June 2021), Article 104862

Jennifer Loschwitz, Anna Jäckering, Birgit Strodel


9. SARS-CoV-2 diagnostics: Towards a more comprehensive approach to routine patient testing

Journal of Immunological Methods, 27 March 2021, Volume 494 (Cover date: July 2021), Article 113044

Clive Carter, Pamela Hughes, Brendan Clark


10. Genome-wide analysis of 10664 SARS-CoV-2 genomes to identify virus strains in 73 countries based on single nucleotide polymorphism

Virus Research, 26 March 2021, Volume 298 (Cover date: June 2021), Article 198401

Nimisha Ghosh, Indrajit Saha, Dariusz Plewczynski


11. The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety

Vaccine, 6 March 2021, Volume 39, Issue 19 (Cover date: 6 May 2021), Pages 2712-2718

Steven B. Black, Barbara Law, Greg Poland


12. Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortality

EClinicalMedicine, 26 April 2021, Volume 35 (Cover date: May 2021), Article 100863

Fardad Haghpanah, Gary Lin, Eili Klein


13. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Cell, 12 March 2021, Volume 184, Issue 9 (Cover date: 29 April 2021), Pages 2372-2383.e9

Wilfredo F. Garcia-Beltran, Evan C. Lam, Alejandro B. Balazs


14. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

Cell, 20 March 2021, Volume 184, Issue 9 (Cover date: 29 April 2021), Pages 2384-2393.e12

Markus Hoffmann, Prerna Arora, Stefan Pöhlmann


15. Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation

iScience, 10 March 2021, Volume 24, Issue 4 (Cover date: 23 April 2021), Article 102298

Brunda Ganneru, Harsh Jogdand, Krishna Mohan Vadrevu


16. Comparison of two commercial surrogate ELISAs to detect a neutralising antibody response to SARS-CoV-2

Journal of Virological Methods, 8 March 2021, Volume 292 (Cover date: June 2021), Article 114122

Katharina Müller, Philipp Girl, Roman Wölfel


17. Assessment of SARS-CoV-2 specific CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers

Vaccine, 5 March 2021, Volume 39, Issue 15 (Cover date: 8 April 2021), Pages 2110-2116

Yuri Poluektov, Marybeth George, Marc C. Delcommenne


18. Expression of SARS-CoV-2 surface glycoprotein fragment 319–640 in E. coli, and its refolding and purification

Protein Expression and Purification, 2 March 2021, Volume 183 (Cover date: July 2021), Article 105861

Gabriel A. Fitzgerald, Andrei Komarov, Maria L. Kireeva



1. Evaluation of seven commercial RT-PCR kits for COVID-19 testing in pooled clinical specimens

Garg A, Ghoshal U, Patel SS, Singh DV, Arya AK, Vasanth S, Pandey A, Srivastava N.

J Med Virol. 2021 Apr;93(4):2281-2286


2. Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients

Alharthy A, Aletreby W, Faqihi F, Balhamar A, Alaklobi F, Alanezi K, Jaganathan P, Tamim H, Alqahtani SA, Karakitsos D, Memish ZA.

J Epidemiol Glob Health. 2021 Mar;11(1):98-104


3. Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial

Madariaga MLL, Guthmiller JJ, Schrantz S, Jansen MO, Christensen C, Kumar M, Prochaska M, Wool G, Durkin-Celauro A, Oh WH, Trockman L, Vigneswaran J, Keskey R, Shaw DG, Dugan H, Zheng NY, Cobb M, Utset H, Wang J, Stovicek O, Bethel C, Matushek S, Giurcanu M, Beavis KG, di Sabato D, Meltzer D, Ferguson MK, Kress JP, Shanmugarajah K, Matthews JB, Fung JF, Wilson PC, Alverdy JC, Donington JS.

J Intern Med. 2021 Apr;289(4):559-573.


4. Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients

Zayet S, Klopfenstein T, Mercier J, Kadiane-Oussou NJ, Lan Cheong Wah L, Royer PY, Toko L, Gendrin V.

Infection. 2021 Apr;49(2):361-365.


5. Epidemiological Features of 105 Patients Infected with the COVID-19

Shi JC, Yu ZJ, He GQ, Chen W, Ye XC, Wu ZX, Zhu XQ, Pan JZ, Jiang XG.

J Natl Med Assoc. 2021 Apr;113(2):212-217.


6. Patterns of repeated diagnostic testing for COVID-19 in relation to patient characteristics and outcomes

Salerno S, Zhao Z, Prabhu Sankar S, Salvatore M, Gu T, Fritsche LG, Lee S, Lisabeth LD, Valley TS, Mukherjee B.

J Intern Med. 2021 May;289(5):726-737.



1. Effect of influenza vaccine on COVID-19 mortality: a retrospective study

Marcello Candelli, Giulia Pignataro, Enrico Torelli… in Internal and Emergency Medicine (2021)


2. The role of PoCUS in the assessment of COVID-19 patients

John Karp, Karina Burke, Sarah-Marie Daubaras, Cian McDermott in Journal of Ultrasound (2021)


3. Post-traumatic Stress Disorder Among COVID-19 Survivors at 3-Month Follow-up After Hospital Discharge

Lorenzo Tarsitani MD, PhD, Paolo Vassalini MD… in Journal of General Internal Medicine (2021)


4. Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling

Xueyan Xi, Yang Guo, Min Zhu, Yuhui Wei, Gang Li, Boyu Du, Yunfu Wang in Virology Journal (2021)


5. Evaluation of ocular symptoms in COVID-19 subjects in inpatient and outpatient settings

Betül İlkay Sezgin Akçay, Esra Kardeş, Gülünay Kıray… in International Ophthalmology (2021)


6. Semi-quantitative CT severity scoring as a predictor of development of post-COVID syndrome

Mohammad A. Saad, Ahmed F. El Khateeb… in Egyptian Journal of Radiology and Nuclear … (2021)


7. Comparative study of hospitalized children with acute respiratory distress syndrome caused by SARS-CoV-2 and influenza virus

Xinghua Liu, Wei Li, Bo Zhang, Yan Guo, Zhao Hu, Cao Peng… in BMC Infectious Diseases (2021)


8. A novel pseudovirus‐based mouse model of SARS-CoV-2 infection to test COVID-19 interventions

Ssu-Hsueh Tseng, Brandon Lam, Yu Jui Kung, John Lin… in Journal of Biomedical Science (2021)


9. Salivary testing of COVID-19: evaluation of serological testing following positive salivary results

Lisa Caulley, Julie Shaw, Martin Corsten, Nadia Hua… in BMC Infectious Diseases (2021)


10. Investigation of potential inhibitor properties of ethanolic propolis extracts against ACE-II receptors for COVID-19 treatment by molecular docking study

Halil Ibrahim Guler, Gizem Tatar, Oktay Yildiz… in Archives of Microbiology (2021)


11. Classification of COVID-19 pneumonia from chest CT images based on reconstructed super-resolution images and VGG neural network

Wenjun Tan, Pan Liu, Xiaoshuo Li, Yao Liu… in Health Information Science and Systems (2021)


12. High body mass index is a significant risk factor for the progression and prognosis of imported COVID-19: a multicenter, retrospective cohort study

Huan Cai, Lisha Yang, Yingfeng Lu, Shanyan Zhang, Chanyuan Ye… in BMC Infectious Diseases (2021)


Nguôn: Cục Thông tin Khoa học và công nghê Quôc gia